Literature DB >> 10598844

Characterization of breast masses by dynamic enhanced MR imaging. A logistic regression analysis.

O Ikeda1, Y Yamashita, S Morishita, T Kido, M Kitajima, K Okamura, S Fukuda, M Takahashi.   

Abstract

PURPOSE: To identify features useful for differentiation between malignant and benign breast neoplasms using multivariate analysis of findings by MR imaging.
MATERIAL AND METHODS: In a retrospective analysis, 61 patients with 64 breast masses underwent MR imaging and the time-signal intensity curves for precontrast dynamic postcontrast images were quantitatively analyzed. Statistical analysis was performed using a logistic regression model, which was prospectively tested in another 34 patients with suspected breast masses.
RESULTS: Univariate analysis revealed that the reliable indicators for malignancy were first the appearance of the tumor border, followed by the washout ratio, internal architecture after contrast enhancement, and peak time. The factors significantly associated with malignancy were irregular tumor border, followed by washout ratio, internal architecture, and peak time. For differentiation between benignity and malignancy, the maximum cut-off point was to be found between 0.47 and 0.51. In a prospective application of this model, 91% of the lesions were accurately discriminated as benign or malignant lesions.
CONCLUSION: Combination of contrast-enhanced dynamic and postcontrast-enhanced MR imaging provided accurate data for the diagnosis of malignant neoplasms of the breast. The model had an accuracy of 91% (sensitivity 90%, specificity 93%).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598844     DOI: 10.3109/02841859909175592

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  7 in total

1.  A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings.

Authors:  Luminita A Tudorica; Karen Y Oh; Nicole Roy; Mark D Kettler; Yiyi Chen; Stephanie L Hemmingson; Aneela Afzal; John W Grinstead; Gerhard Laub; Xin Li; Wei Huang
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI.

Authors:  Xiaobing Fan; Milica Medved; Gregory S Karczmar; Cheng Yang; Sean Foxley; Sanaz Arkani; Wendy Recant; Marta A Zamora; Hiroyuki Abe; Gillian M Newstead
Journal:  Magn Reson Imaging       Date:  2006-11-30       Impact factor: 2.546

3.  Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.

Authors:  Anna G Sorace; Savannah C Partridge; Xia Li; Jack Virostko; Stephanie L Barnes; Daniel S Hippe; Wei Huang; Thomas E Yankeelov
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-22

4.  Invasive breast cancer: correlation of dynamic MR features with prognostic factors.

Authors:  Botond K Szabó; Peter Aspelin; Maria Kristoffersen Wiberg; Tibor Tot; Beata Boné
Journal:  Eur Radiol       Date:  2003-07-26       Impact factor: 5.315

5.  Application of artificial neural networks to the analysis of dynamic MR imaging features of the breast.

Authors:  Botond K Szabó; Maria Kristoffersen Wiberg; Beata Boné; Peter Aspelin
Journal:  Eur Radiol       Date:  2004-03-18       Impact factor: 5.315

6.  The added diagnostic value of dynamic contrast-enhanced MRI at 3.0 T in nonpalpable breast lesions.

Authors:  Laura G Merckel; Helena M Verkooijen; Nicky H G M Peters; Ritse M Mann; Wouter B Veldhuis; Remmert K Storm; Teun Weits; Katya M Duvivier; Thijs van Dalen; Willem P Th M Mali; Petra H M Peeters; Maurice A A J van den Bosch
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

7.  Semi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis.

Authors:  Alan Jackson; Ka-Loh Li; Xiaoping Zhu
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.